UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app, called DBm-Health, assists users to monitor their blood glucose levels and send readings, notes and medication information to their healthcare practitioner to assess remotely. It is a follow-on to Sensyne’s GDm-Health product,
Novo Nordisk launched the strategy Defeat Diabetes, which introduces new long-term ambitions to provide access to affordable diabetes care to vulnerable patients in every country and ensure that no child should die from type 1 diabetes. One in every 11 people in the world has diabetes, a figure believed to increase to one in nine
German pharmaceutical company, Merck, will soon be trialling a digital behavioural change programme that combines remote health coaching, peer support and connected technology in a variety of countries outside the US. Merck will be working with Blue Mesa Health to provide the US digital therapeutics firm’s chronic disease prevention programme to diabetes patients. Last year,
The Danish pharmaceutical company plans to use voice-activated technology such as Amazon’s Alexa to improve diabetes care have taken a step forward. Novo Nordisk have teamed up with HITLAB (Health Innovation Technology Lab) last year to support its 17th health innovation World Cup, which focused for the first time on voice tech in type 2
A smartphone app that aids pregnant women to manage gestational diabetes has been approved to become part of the NHS Apps Library. The app, which was developed by Drayson Technologies, GDm-Health, addresses gestational diabetes mellitus (GDm), a form of glucose intolerance that begins during pregnancy and resolves following birth. This form of diabetes can be
The digital health deal between Novo Nordisk’s and Glooko produced a new diabetes management app, C4C that they hope will assist users to better manage the condition. The C4C app also includes relevant content and resources from Novo’s Cornerstones4Care personalised support programme. David Moore, senior vice president of marketing at Novo Nordisk, said: “In today’s
Novo Nordisk and Glooko have announced that they will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data expertise. Building upon Glooko’s mobile and web platforms, the companies aim to deliver personalised services
